Lumida
/TBPH
⌘K
Theravance Biopharma Inc

Theravance Biopharma Inc

TBPH
$16.93USD-0.24%-0.04 today

MARKET CAP

877.5M

P/E (TTM)

FWD P/E

8.7x

DAY RANGE

$17 – $17

52W RANGE

$11
$21

AI Summary

Stalk
Buy NowMedium

TBPH is exhibiting signs of structural repair with a Bullish Pivot Point pattern and price holding above key short-term EMAs. The intermediate trend is supported by mean-reversion dynamics, while the long-term uptrend remains intact. EMAs are flattening and turning higher, and RSI and Options Score show no exhaustion. The momentum-focused strategy favors participation on shallow pullbacks into rising EMA support.

  • $333M cash position and zero debt support trial funding
  • UPelry Q1 net sales $71.4M (+15% YoY); hospital doses +49%
  • Approval binary risk high: pending Phase III Cypress outcomes
Full analysis →
Insider Trades82 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 15, 2026SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS13,314$16.39$877.5M-19.50%+56.44%$218.2K-1.83%Buy Now
May 20, 2026SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS5,678$16.55$877.5M-19.50%+56.44%$94.0K-2.26%Buy Now
May 20, 2026SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE6,827$16.55$877.5M-19.50%+56.44%$113.0K-3.71%Buy Now
May 20, 2026SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER8,670$16.55$877.5M-19.50%+56.44%$143.5K-2.45%Buy Now
May 20, 2026SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY8,829$16.55$877.5M-19.50%+56.44%$146.1K-2.37%Buy Now
May 20, 2026SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER20,038$16.55$877.5M-19.50%+56.44%$331.6K-1.21%Buy Now
Mar 16, 2026SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS31,067$13.96$877.5M-19.50%+56.44%$433.6K-4.09%Buy Now
Feb 20, 2026SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS13,929$19.66$877.5M-19.50%+56.44%$273.8K-5.02%Buy Now
Feb 20, 2026SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE16,851$19.66$877.5M-19.50%+56.44%$331.3K-8.38%Buy Now
Feb 20, 2026SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER20,672$19.66$877.5M-19.50%+56.44%$406.4K-6.14%Buy Now
Feb 20, 2026SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY20,833$19.66$877.5M-19.50%+56.44%$409.6K-5.86%Buy Now
Feb 20, 2026SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER74,975$19.66$877.5M-19.50%+56.44%$1.5M-4.54%Buy Now
Dec 3, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS31,067$18.75$877.5M-19.50%+56.44%$582.5K-3.44%Buy Now
Nov 20, 2025SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE6,989$17.90$877.5M-19.50%+56.44%$125.1K-3.36%Buy Now
Nov 20, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS9,060$17.90$877.5M-19.50%+56.44%$162.2K-2.85%Buy Now
Nov 20, 2025SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER18,627$17.90$877.5M-19.50%+56.44%$333.4K-5.24%Buy Now
Nov 20, 2025SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY19,024$17.90$877.5M-19.50%+56.44%$340.5K-5.08%Buy Now
Nov 19, 2025SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER76,617$13.27$877.5M-19.50%+56.44%$1.0M-1.65%Buy Now
Aug 20, 2025SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE6,989$13.39$877.5M-19.50%+56.44%$93.6K-3.25%Buy Now
Aug 20, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS9,096$13.39$877.5M-19.50%+56.44%$121.8K-2.78%Buy Now
Aug 20, 2025SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER9,368$13.39$877.5M-19.50%+56.44%$125.4K-2.57%Buy Now
Aug 20, 2025SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY9,762$13.39$877.5M-19.50%+56.44%$130.7K-2.54%Buy Now
Aug 20, 2025SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER15,394$13.39$877.5M-19.50%+56.44%$206.1K-0.89%Buy Now
Jul 14, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS10,000$11.39$877.5M-19.50%+56.44%$113.9K-1.00%Buy Now
Jun 23, 2025SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER20,000$10.57$877.5M-19.50%+56.44%$211.4K-1.14%Buy Now
Jun 13, 2025SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER19,200$10.69$877.5M-19.50%+56.44%$205.2K+0.00%Buy Now
Jun 2, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS24,000$11.00$877.5M-19.50%+56.44%$264.0K-6.65%Buy Now
May 20, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS9,120$9.45$877.5M-19.50%+56.44%$86.2K-2.46%Buy Now
May 20, 2025SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER9,348$9.45$877.5M-19.50%+56.44%$88.3K-2.50%Buy Now
May 20, 2025SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE9,701$9.45$877.5M-19.50%+56.44%$91.7K-4.32%Buy Now
May 20, 2025SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY9,743$9.45$877.5M-19.50%+56.44%$92.1K-2.47%Buy Now
May 20, 2025SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER15,364$9.45$877.5M-19.50%+56.44%$145.2K-0.86%Buy Now
Apr 21, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS4,000$9.00$877.5M-19.50%+56.44%$36.0K-1.07%Buy Now
Feb 28, 2025BuyTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER2,178$9.35$877.5M-19.50%+56.44%$20.4K+0.12%Buy Now
Feb 20, 2025SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE11,295$9.66$877.5M-19.50%+56.44%$109.1K-7.50%Buy Now
Feb 20, 2025SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER13,751$9.66$877.5M-19.50%+56.44%$132.8K-4.39%Buy Now
Feb 20, 2025SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY14,534$9.66$877.5M-19.50%+56.44%$140.4K-4.36%Buy Now
Feb 20, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS15,810$9.66$877.5M-19.50%+56.44%$152.7K-5.02%Buy Now
Feb 20, 2025SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER35,129$9.66$877.5M-19.50%+56.44%$339.3K-1.94%Buy Now
Jan 21, 2025SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS4,000$9.00$877.5M-19.50%+56.44%$36.0K-1.28%Buy Now
Nov 20, 2024SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER8,477$9.97$877.5M-19.50%+56.44%$84.5K-2.64%Buy Now
Nov 20, 2024SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS9,178$9.97$877.5M-19.50%+56.44%$91.5K-2.84%Buy Now
Nov 20, 2024SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY9,268$9.97$877.5M-19.50%+56.44%$92.4K-2.71%Buy Now
Nov 20, 2024SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE10,076$9.97$877.5M-19.50%+56.44%$100.5K-6.27%Buy Now
Nov 20, 2024SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER15,997$9.97$877.5M-19.50%+56.44%$159.5K-0.88%Buy Now
Nov 14, 2024BuyTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER3,193$9.57$877.5M-19.50%+56.44%$30.6K+0.18%Buy Now
Nov 11, 2024SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS4,000$9.00$877.5M-19.50%+56.44%$36.0K-1.22%Buy Now
Aug 20, 2024SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE5,201$8.22$877.5M-19.50%+56.44%$42.8K-3.14%Buy Now
Aug 20, 2024SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER8,635$8.22$877.5M-19.50%+56.44%$71.0K-2.62%Buy Now
Aug 20, 2024SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS9,222$8.22$877.5M-19.50%+56.44%$75.8K-2.74%Buy Now
Aug 20, 2024SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY9,268$8.22$877.5M-19.50%+56.44%$76.2K-2.63%Buy Now
Aug 20, 2024SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER15,997$8.22$877.5M-19.50%+56.44%$131.5K-0.87%Buy Now
Aug 7, 2024BuyTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER3,252$7.83$877.5M-19.50%+56.44%$25.5K+0.18%Buy Now
Jul 10, 2024SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS4,000$9.00$877.5M-19.50%+56.44%$36.0K-1.18%Buy Now
May 20, 2024SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE5,201$9.10$877.5M-19.50%+56.44%$47.3K-3.04%Buy Now
May 20, 2024SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER8,635$9.10$877.5M-19.50%+56.44%$78.6K-2.55%Buy Now
May 20, 2024SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS9,268$9.10$877.5M-19.50%+56.44%$84.3K-2.65%Buy Now
May 20, 2024SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY9,268$9.10$877.5M-19.50%+56.44%$84.3K-2.57%Buy Now
May 20, 2024SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER15,997$9.10$877.5M-19.50%+56.44%$145.6K-0.86%Buy Now
May 15, 2024BuyTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER2,068$9.85$877.5M-19.50%+56.44%$20.4K+0.11%Buy Now
Mar 15, 2024SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER17,504$1.33$877.5M-19.50%+56.44%$23.4K-0.09%Buy Now
Feb 20, 2024SellTBPHAine MillerSVP, DEV & HEAD OF IRE OFFICE11,782$8.92$877.5M-19.50%+56.44%$105.1K-8.11%Buy Now
Feb 20, 2024SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER17,036$8.92$877.5M-19.50%+56.44%$152.0K-6.66%Buy Now
Feb 20, 2024SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY17,595$8.92$877.5M-19.50%+56.44%$156.9K-6.32%Buy Now
Feb 20, 2024SellTBPHRichard A GrahamSVP, RESEARCH & DEVELOPMENT19,294$8.92$877.5M-19.50%+56.44%$172.1K-5.77%Buy Now
Feb 20, 2024SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS19,473$8.91$877.5M-19.50%+56.44%$173.4K-3.02%Buy Now
Feb 20, 2024SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER37,196$8.92$877.5M-19.50%+56.44%$331.8K-2.33%Buy Now
Nov 20, 2023SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER6,187$10.37$877.5M-19.50%+56.44%$64.2K-2.36%Buy Now
Nov 20, 2023SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY7,363$10.37$877.5M-19.50%+56.44%$76.4K-2.58%Buy Now
Nov 20, 2023SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS9,360$10.36$877.5M-19.50%+56.44%$97.0K-1.39%Buy Now
Nov 20, 2023SellTBPHRichard A GrahamSVP, RESEARCH & DEVELOPMENT12,630$10.37$877.5M-19.50%+56.44%$131.0K-3.64%Buy Now
Nov 20, 2023SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER15,804$10.37$877.5M-19.50%+56.44%$163.9K-0.98%Buy Now
Nov 14, 2023SellTBPHRichard A GrahamSVP, RESEARCH & DEVELOPMENT2,482$10.22$877.5M-19.50%+56.44%$25.4K-0.71%Buy Now
Oct 16, 2023SellTBPHRichard A GrahamSVP, RESEARCH & DEVELOPMENT2,482$9.03$877.5M-19.50%+56.44%$22.4K-0.74%Buy Now
Sep 14, 2023SellTBPHRichard A GrahamSVP, RESEARCH & DEVELOPMENT2,482$9.89$877.5M-19.50%+56.44%$24.5K-0.73%Buy Now
Aug 22, 2023SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS1,807$9.47$877.5M-19.50%+56.44%$17.1K-0.53%Buy Now
Aug 20, 2023SellTBPHAziz SawafSVP & CHIEF FINANCIAL OFFICER7,114$9.70$877.5M-19.50%+56.44%$69.0K-2.64%Buy Now
Aug 20, 2023SellTBPHBrett A. GrimaudSVP, GEN COUNSEL AND SECRETARY8,912$9.70$877.5M-19.50%+56.44%$86.4K-3.03%Buy Now
Aug 20, 2023SellTBPHRhonda FarnumSVP, COMM & MEDICAL AFFAIRS10,460$9.70$877.5M-19.50%+56.44%$101.5K-2.96%Buy Now
Aug 20, 2023SellTBPHRichard A GrahamSVP, RESEARCH & DEVELOPMENT10,461$9.70$877.5M-19.50%+56.44%$101.5K-2.99%Buy Now
Aug 20, 2023SellTBPHRick E WinninghamCHIEF EXECUTIVE OFFICER15,804$9.70$877.5M-19.50%+56.44%$153.3K-0.97%Buy Now
Aug 11, 2023SellTBPHRichard A GrahamSVP, RESEARCH & DEVELOPMENT2,322$9.99$877.5M-19.50%+56.44%$23.2K-0.66%Buy Now